Expert profile

Dr. Ziyad Al-Aly

Clinical epidemiologist and Long COVID researcher

Long COVID • post-viral chronic disease • multi-organ effects of SARS-CoV-2 • large-scale electronic health record research

1Discussion
41 minAnalysed
Last reviewed: Jun 7, 2026·Credential: MD, MPH, MSc (Clinical Epidemiology)·First indexed: Jun 7, 2026

About the expert

Focus: Leading research on Long COVID's multi-organ impacts and infection-associated chronic disease, using large-scale health data

Chief of Research and Development at the Veterans Affairs St. Louis Health Care System, Clinical Epidemiologist. Pioneered the use of the VA's large electronic health record system to study Long COVID, producing some of the most cited research on multi-organ effects of SARS-CoV-2 (including the link to new-onset diabetes). Background includes a transition from computer science to medicine. Strong NIH/Nature-published track record. Advocates for permanent research infrastructure for infection-associated chronic illnesses. Mainstream-anchored research, frequently published in Nature, NEJM, JAMA.

Expert discussions with Dr. Ziyad Al-Aly

Illuminating Long Covid: Ground Truths Podcast with Ziyad Al-Aly and Eric Topol
Long COVID may quietly affect many organ systems for months or years after the acute infection clears. The risk is real even after mild infections and includes new-onset diabetes, heart, kidney, and brain effects. Re-infection appears to add to the risk, not reset it.